From parenteral to enteral nutrition: a nutrition-based approach for evaluating postnatal growth failure in preterm

Malki Miller1, Ruben Vaidya, Deepa Rastogi

  • 1Department of Nutrition, Maimonides Infants and Children's Hospital, Brooklyn, New York.

Insights

Poor growth in preterm infants is most common during the transitional nutrition phase, increasing the risk of growth failure at discharge. Optimizing protein intake during this phase is crucial for preventing growth failure.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Growth Monitoring

Background:

  • Preterm infant nutrition involves parenteral nutrition (PN), enteral nutrition (EN), and a transitional phase.
  • Growth failure (GF) at discharge is a significant concern for preterm infants.
  • Identifying critical nutrition phases for poor growth is essential for intervention.

Purpose of the Study:

  • To determine during which nutrition phase preterm infants are most likely to experience poor growth.
  • To identify factors associated with growth failure at discharge.
  • To examine the impact of nutrition phases on growth inadequacy.

Main Methods:

  • Retrospective chart review of infants born <32 weeks' gestation.
  • Division of neonatal intensive care unit stay into three nutrition phases: full PN, transitional PN + EN, and full EN.
  • Calculation of weekly growth rates and definition of growth failure as discharge weight below the 10th percentile.

Main Results:

  • Poor growth occurred most frequently during the transitional phase (46%) and predicted discharge growth failure.
  • Protein intake decreased significantly during the transitional phase as PN was weaned.
  • Declining serum urea nitrogen correlated with reduced protein intake.

Conclusions:

  • Growth is compromised during the transitional nutrition phase in preterm infants, primarily due to decreased protein intake.
  • Optimizing protein delivery during PN weaning is a key strategy to prevent postnatal growth failure.
  • Targeted nutritional interventions during the transitional phase can improve growth outcomes.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...